Enhanced in vivo thromboxane biosynthesis in melanoma compared with basal cell carcinoma skin cancers
Giovanna Petrucci, Alessandro Di Stefani, Alessandro Rizzi, Lucia Di Nardo, Laura Del Regno, Mohammad A Farhoud, Ketty Peris, Bianca Rocca · 2026
Read Enhanced in vivo thromboxane biosynthesis in melanoma compared with basal cell carcinoma skin cancers by Giovanna Petrucci, Alessandro Di Stefani, Alessandro Rizzi, Lucia Di Nardo, Laura Del Regno, Mohammad A Farhoud, Ketty Peris, Bianca Rocca (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13623437.txt.
Description
Giovanna Petrucci and colleagues published a 2026 study asking whether melanoma, the most dangerous skin cancer, switches on platelet activity in the body. Activated platelets release thromboxane, a chemical that helps tumours grow in several gut cancers. The team measured a urine breakdown product of thromboxane as a stand-in for platelet activity, and a second marker for another inflammatory chemical.
The study compared thirty patients with stage one to three melanoma, twenty-four with basal cell carcinoma, a milder skin cancer, and thirty-eight healthy volunteers matched by age and sex. The thromboxane marker ran higher in melanoma patients than in either other group, while the basal cell group looked like healthy controls. Six stage four melanoma patients showed the highest levels of all. The second marker did not differ between groups. The authors propose the urine test as a warning sign for melanoma worsening, worth testing further.
Catalog record
| CREATOR | Giovanna Petrucci, Alessandro Di Stefani, Alessandro Rizzi, Lucia Di Nardo, Laura Del Regno, Mohammad A Farhoud, Ketty Peris, Bianca Rocca |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |